[1]
“Management of Chronic Myeloid Leukemia that is Intolerant or Resistant to Front-Line Treatment”, Can Hematol Today, vol. 3, no. 2, pp. 31–39, Jun. 2024, doi: 10.58931/cht.2024.3253.